The Cutaneous Lymphoma Foundation (CLF) is pleased to announce Filiberto Cedeno Laurent, MD, PhD, as the recipient of its Young Investigator Award (YIA) travel grant.
Dr. Cedeno Laurent’s research will focus on the reduction of IL-31 expression to suppress pruritus in cutaneous T-cell lymphoma. His preliminary studies have shown that various therapeutic agents used to treat cutaneous T-cell lymphoma effectively mitigate pruritus in patients and that response is directly correlated with lower levels of IL-31. Therefore, the data reveals the relevance of blocking the IL-31 pathway for symptomatic relief of patients with
intractable pruritus in cutaneous T-Cell lymphoma and potentially other conditions.
“We are thrilled to support Dr. Laurent in his efforts to better understand itch in cutaneous lymphomas,” said Susan Thornton, Chief Executive Officer, Cutaneous Lymphoma Foundation. “Itch is often one of the most debilitating symptoms for patients suffering from this rare disease, and one of the most difficult for researchers to understand. His findings could potentially change the lives of thousands of patients impacted by itch, not only with cutaneous lymphoma, but other diseases as well.”
Dr. Cedeno Laurent is currently a first year resident and cutaneous oncology fellow at the University of Pennsylvania. He is responsible for overseeing the care of advanced cutaneous T-cell lymphoma patients, particularly a large numbers of Sezary syndrome patients. Dr. Cedeno Laurent earned his combined BS-MD from the Escuela de Medicina Ignacio A. Santos Monterrey, Mexico and completed his Medical Social Service at the Autonomous University of the State of Mexico, Toluca, Mexico. He earned his PhD in immunology from Harvard Medical School and has pursued Post-Doctoral research fellowships in HIV/AIDS at the University of Maryland and anti-tumor immunity at the Brigham and Women’s Hospital.
The YIA, now in it’s eleventh year, is a travel grant presented annually at the Society for Investigative Dermatology (SID), and is given to support travel of a young cutaneous lymphoma researcher to the SID Annual Meeting and participation in the concurrent International Society for Cutaneous Lymphomas Scientific & Annual General Meeting and Cutaneous T-Cell Lymphoma Symposium.